Central and peripheral neurological complications of primary Sjögren's syndrome

Presse Medicale

Volumn 41, Issue 9 PART2, 2012, Pages

  Fauchais, Anne Laure ^a   Magy, Laurent ^a   Vidal, Elisabeth ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CRANIAL NEUROPATHY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROPHYSIOLOGY; ENCEPHALITIS; HUMAN; MENINGOENCEPHALITIS; MULTIPLE SCLEROSIS; NERVE BIOPSY; NEUROPATHY; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIMARY SJOEGREN SYNDROME; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; SHORT SURVEY; SJOEGREN SYNDROME; SMALL FIBER NEUROPATHY; SPINAL CORD DISEASE; SYMPTOMATOLOGY; TREATMENT INDICATION; VASCULITIS;

EID: 84865978328     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.06.002     Document Type: Short Survey

References (72)

1. Mellgren S.I., Conn D.L., Stevens J.C., Dyck P.J. Peripheral neuropathy in primary Sjögren's syndrome. Neurology 1989, 39:390-394.
2. Kelly C.A., Foster H., Pal B., et al. Primary Sjögren's syndrome in north east England-a longitudinal study. Br J Rheumatol 1991, 30:437-442.
3. Moll J.W., Markusse H.M., Pijnenburg J.J., Vecht C.J., Henzen-Logmans S.C. Anti-neuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome. Neurology 1993, 43:2574-2581.
4. Mauch E., Volk C., Kratzsch G., et al. Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome. Acta Neurol Scand 1994, 89:31-35.
5. Govoni M., Bajocchi G., Rizzo N., et al. Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol 1999, 18:299-303.
6. Ramos-Casals M., Solans R., Rosas J., et al. Primary Sjögren's syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
7. Gono T., Kawaguchi Y., Katsumata Y., et al. Clinical manifestations of neurological involvement in primary Sjögren's syndrome. Clin Rheumatol 2011, 30(4):485-490.
8. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., et al. Peripheral neuropathies in Sjögren's syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2011, 82(7):798-802.
9. Sene D., Jallouli M., Lefaucheur J.P., et al. Peripheral neuropathies associated with primary Sjögren's syndrome: Immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine (Baltimore) 2011, 90:133-138.
10. Alexander E.L., Provost T.T., Stevens M.B., Alexander G.E. Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) 1982, 61:247-257.
11. Delalande S., de Seze J., Fauchais A.L., et al. Neurologic manifestations in primary Sjögren's syndrome: a study of 82 patients. Medicine (Baltimore) 2004, 83:280-291.
12. Barendregt P., van den Bent M., van Raaij-van den Aarssen V., et al. Involvement of the peripheral nervous system in primary Sjögren's syndrome. Ann Rheum Dis 2001, 60:876-881.
13. Mori K., Iijima M., Koike H., et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005, 128:2518-2534.
14. Andonopoulos A.P., Lagos G., Drosos A.A., Moutsopoulos H.M. The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol 1990, 29:21-23.
15. Font J., Ramos-Casals M., de la Red G., et al. Pure sensory neuropathy in primary Sjögren's syndrome. Long-term prospective follow-up and review of the literature. J Rheumatol 2003, 30:1552-1557.
16. Lopate G., Pestronk A., Al-Lozi M., et al. Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome. Muscle Nerve 2006, 33:672-676.
17. Griffin J.W., Cornblath D.R., Alexander E., et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 1990, 27:304-315.
18. Peyronnard J.M., Charron L., Beaudet F., Couture F. Vasculitic neuropathy in rheumatoid disease and Sjögren's syndrome. Neurology 1982, 32:839-845.
19. Bouhassira D., Attal N., Alchaar H., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (dn4). Pain 2005, 114:29-36.
20. Gemignani F., Marbini A., Pavesi G., et al. Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry 1994, 57:983-986.
21. Goransson L.G., Herigstad A., Tjensvoll A.B., Harboe E., Mellgren S.I., Omdal R. Peripheral neuropathy in primary Sjögren's syndrome: a population-based study. Arch Neurol 2006, 63:1612-1615.
22. Grant I.A., Hunder G.G., Homburger H.A., Dyck P.J. Peripheral neuropathy associated with sicca complex. Neurology 1997, 48:855-862.
23. Graus F., Pou A., Kanterewicz E., Anderson N.E. Sensory neuronopathy and Sjögren's syndrome: clinical and immunologic study of two patients. Neurology 1988, 38:1637-1639.
24. Apartis E., Leger J.M., Musset L., et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis c virus infection?. J Neurol Neurosurg Psychiatry 1996, 60:661-666.
25. Ferri C., La Civita L., Cirafisi C., et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992, 19:889-895.
26. Gemignani F., Pavesi G., Fiocchi A., Manganelli P., Ferraccioli G., Marbini A. Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 1992, 55:116-120.
27. Fauchais A.L., Martel C., Gondran G., et al. Immunological profile in primary Sjögren's syndrome clinical significance, prognosis and long-term evolution to other autoimmune disease. Autoimmun Rev 2010, 9(9):595-599.
28. Hietaharju A., Korpela M., Ilonen J., Frey H. Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome. Ann Rheum Dis 1992, 51:506-509.
29. Anaya J.M., Villa L.A., Restrepo L., Molina J.F., Mantilla R.D., Vargas S. Central nervous system compromise in primary Sjögren's syndrome. J Clin Rheumatol 2002, 8:189-196.
30. Fauchais A.L., Ouattara B., Gondran G., et al. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford) 2010, 49:1164-1172.
31. Ramos-Casals M., Brito-Zeron P., Perez-De-Lis M., et al. Sjögren syndrome or Sjögren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2010, 38:178-185.
32. Garcia-Carrasco M., Ramos-Casals M., Rosas J., et al. Primary Sjögren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002, 81:270-280.
33. Molina R., Provost T.T., Alexander E.L. Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications. Arthritis Rheum 1985, 28:1341-1347.
34. Alexander E. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and up- date of immunopathogenesis. Rheum Dis Clin North Am 1993, 19:869-908.
35. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren's syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88:284-293.
36. Kondo T., Inoue H., Usui T., et al. Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach. Auton Neurosci 2009, 146:33-35.
37. Morozumi S., Kawagashira Y., Iijima M., et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. J Neurol Sci 2009, 279:57-61.
38. Cai F.Z., Ahern M., Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol 2006, 33:1197-1198.
39. Ferri C., Cacoub P., Mazzaro C., et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011, 11:48-55.
40. Chai J., Herrmann D.N., Stanton M., Barbano R.L., Logigian E.L. Painful small fiber neuropathy in Sjögren's syndrome. Neurology 2005, 65(6):925-927.
41. Mori K., Iijima M., Sugiura M., et al. Sjögren's syndrome-associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry 2003, 74:1320-1322.
42. Fauchais A.L., Richard L., Gondran G., et al. Small fiber neuropathy in primary Sjögren's syndrome-a monocentric experience. Rev Med Int 2010 2011, 32(3):142-148.
43. Alexander E.L., Malinow K., Lejewski J.E., Jerdan M.S., Provost T.T., Alexander G.E. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986, 104:323-330.
44. Rafai M.A., Boulaajaj F.Z., Moutawakil F., et al. Neurological manifestations revealing primitive Gougerot-Sjögren syndrome: 9 cases. Joint Bone Spine 2009, 76:139-145.
45. Morgen K., McFarland H.F., Pillemer S.R. Central nervous system disease in primary Sjögren's syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 2004, 34:623-630.
46. Mataro M., Escudero D., Ariza M., et al. Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren's syndrome. J Neurol 2003, 250:1070-1076.
47. Thong B.Y., Venketasubramanian N. A case of Sjögren's syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma. Rheumatol Int 2002, 22:256-258.
48. Noseworthy J.H., Bass B.H., Vandervoort M.K., et al. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol 1989, 25:95-98.
49. de Seze J., Devos D., Castelnovo G., et al. The prevalence of Sjögren's syndrome in patients with primary progressive multiple sclerosis. Neurology 2001, 57:1359-1363.
50. Miro J., Pena-Sagredo J.L., Berciano J., Insua S., Leno C., Velarde R. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol 1990, 27:582-584.
51. de Seze J., Delalande S., Fauchais A.L., et al. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids. J Rheumatol 2006, 33:709-711.
52. de Seze J., Dubucquoi S., Fauchais A.L., et al. Alpha fodrin autoantibodies in the differential diagnosis of multiple sclerosis and Sjögren's syndrome. Neurology 2003, 61:268-269.
53. Binard A., Le Pottier L., Devauchelle-Pensec V., Saraux A., Youinou P., Pers J.O. Is the blood b-cell subset profile diagnostic for Sjögren's syndrome?. Ann Rheum Dis 2009, 68:1447-1452.
54. Ichikawa H., Ishihara K., Fujimoto R., et al. An autopsied case of Sjögren's syndrome with massive necrotic and demyelinating lesions of the cerebellar white matter. J Neurol Sci 2004, 225:143-148.
55. Walker R.H., Spiera H., Brin M.F., Olanow C.W. Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature. Mov Disord 1999, 14:262-268.
56. Williams C.S., Butler E., Roman G.C. Treatment of myelopathy in Sjögren's syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001, 58:815-819.
57. Wright R.A., O'Duffy J.D., Rodriguez M. Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy. Neurology 1999, 52:386-388.
58. Arai C., Furutani R., Ushiyama M. A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation. Rinsho Shinkeigaku 2002, 42:613-618.
59. Hawley R.J., Hendricks W.T. Treatment of Sjögren's syndrome myelopathy with azathioprine and steroids. Arch Neurol 2002, 59:875.
60. Hermisson M., Klein R., Schmidt F., Weller M., Kuker W. Myelopathy in primary Sjögren's syndrome: diagnostic and therapeutic aspects. Acta Neurol Scand 2002, 105:450-453.
61. Anantharaju A., Baluch M., Van Thiel D.H. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjögren's syndrome. Dig Dis Sci 2003, 48:830-833.
62. Pericot I., Brieva L., Tintore M., et al. Myelopathy in seronegative Sjögren's syndrome and/or primary progressive multiple sclerosis. Mult Scler 2003, 9:256-259.
63. Kim S.M., Waters P., Vincent A., et al. Sjogren's syndrome myelopathy: spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica. Mult Scler 2009, 15:1062-1068.
64. Le Guern V., Belin C., Henegar C., et al. Cognitive function and 99mtc-ecd brain spect are significantly correlated in patients with primary Sjögren's syndrome: a case-control study. Ann Rheum Dis 2010, 69(1):132-137.
65. Alexander E., Provost T.T. Sjögren's syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 1987, 123:801-810.
66. Alexander E.L., Ranzenbach M.R., Kumar A.J., et al. Anti-ro(ss-a) autoantibodies in central nervous system disease associated with Sjögren's syndrome (cns-ss): clinical, neuroimaging, and angiographic correlates. Neurology 1994, 44:899-908.
67. Coates T., Slavotinek J.P., Rischmueller M., et al. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol 1999, 26:1301-1305.
68. Fauchais A.L., Lambert M., Launay D., et al. Anti-phospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004, 13:245-248.
69. Mekinian A., Ravaud P., Larroche C., et al. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the air registry. Clin Exp Rheumatol 2012, 30(2):208-212.
70. Venegas Fanchke P., Sinning M., Miranda M. Primary Sjögren's syndrome presenting as a generalized chorea. Parkinsonism Relat Disord 2005, 11:193-194.
71. Yoon K.H., Fong K.Y., Koh D.R., Suri R. Central pontine myelinolysis-a rare manifestation of CNS Sjögren's syndrome. Lupus 2000, 9:471-473.
72. Collison K., Rees J. Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjögren's syndrome. J Neurol 2007, 254:1609-1611.